Article information
Full text is only aviable in PDF
References
[1.]
M.C. Freitas, A. Pacheco-Silva, D. Barbosa, et al.
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.
BMC Infect Dis, 6 (2006), pp. 133
[2.]
Clinical and Laboratory Standards Institute.
Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
Fifteenth Informational Supplement,
[3.]
A.K. Petrich, K.E. Luinstra, D. Groves, et al.
Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR.
Mol Cell Probes, 13 (1999), pp. 275-281
[4.]
F.C. Tenover, R.D. Arbeit, R.V. Goering, et al.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J Clin Microbiol, 33 (1995), pp. 2233-2239
[5.]
C.A. Muto, J.A. Jernigan, B.E. Ostrowsky, et al.
SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus.
Infect Control Hosp Epidemiol, 24 (2003), pp. 362-386
[6.]
Y. Carmeli, G.M. Eliopoulos, M.H. Samore.
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Emerg Infect Dis, 8 (2002), pp. 802-807
[7.]
M. Askarian, R. Afkhamzadeh, A. Monabbati, et al.
Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran.
Int J Infect Dis, 12 (2008), pp. 171-175
[8.]
C.A. Muto, E.T. Giannetta, L.J. Durbin, et al.
Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.
Infect Control Hosp Epidemiol, 23 (2002), pp. 429-435
[9.]
C. Aumeran, O. Baud, O. Lesens, et al.
Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France.
Eur J Clin Microbiol Infect Dis, 27 (2008), pp. 1061-1064
[10.]
M. Schmidt-Hieber, I.W. Blau, S. Schwartz, et al.
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.
Int J Hematol, 86 (2007), pp. 158-162
[11.]
M. Ott, H. Wirick.
Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
Can Oper Room Nurs J, 26 (2008), pp. 21-29
[12.]
A. Kurup, M.P. Chlebicki, M.L. Ling, et al.
Control of a hospital-wide vancomycin-resistant enterococci outbreak.
Am J Infect Control, 36 (2008), pp. 206-211
[13.]
M. Peta, E. Carretto, D. Barbarini, et al.
Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
Clin Microbiol Infect, 12 (2006), pp. 163-169
[14.]
M.O. Vernon, M.K. Hayden, W.E. Trick, et al.
Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci.
Arch Intern Med, 166 (2006), pp. 306-312
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
